As shown in Figure 3A, treatment with TGF-β1 at a concentration of 2 ng/mL increased ADAMTS6 expression in H1975 LUAD cells after 24–48 h (log2FC ≥ 1.3) and in SK-MES-1 squamous cell carcinoma cells after 6–48 h (log2FC ≥ 1.2). The gene discussed is TGFB1; the disease is squamous cell carcinoma.